Literature DB >> 27614622

The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.

Nozomu Kishimoto1, Tetsuya Takao2, Sohei Kuribayashi1, Gaku Yamamichi1, Kosuke Nakano1, Masataka Kawamura1, Koichi Tsutahara1, Go Tanigawa1, Seiji Yamaguchi1.   

Abstract

BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation associated with recurrence and poor prognosis in numerous cancer types. The aim of this study was to evaluate the use of the NLR as a biomarker for intravesical recurrence (IVR) in patients undergoing radical nephroureterectomy (RNU) for upper urinary tract urothelial carcinoma (UTUC) for the first time.
METHODS: We retrospectively analyzed the records of 100 patients with UTUC who had undergone RNU between 1999 and 2015 at our institution. The association between the preoperative NLR and IVR were assessed using multivariate models.
RESULTS: Among the 100 patients enrolled in the study, 33 developed IVR during a median follow-up of 34 months. The receiver operating characteristic analysis revealed that the optimum cut-off value for the preoperative NLR was >3.8. A high preoperative NLR (n = 21) was associated with a significantly increased risk of lymph node involvement (p = 0.036) and IVR (p = 0.034) compared with a low preoperative NLR (n = 79). IVR-free survival in patients with a high preoperative NLR was significantly worse than that of patients with a low preoperative NLR (p = 0.018). On multivariate analysis, the preoperative NLR [hazard ratio (HR) 2.49; p = 0.015] and tumor multifocality (HR 2.96; p = 0.024) were independent risk factors predictive of IVR.
CONCLUSION: In our study population of patients with UTUC who had undergone RNU the preoperative NLR was associated with a significantly increased risk of IVR, suggesting that the NRL could be a useful biomarker for predicting IVR.

Entities:  

Keywords:  Intravesical recurrence; Nephroureterectomy; Neutrophil-to-lymphocyte ratio; Upper urinary tract urothelial carcinoma

Mesh:

Year:  2016        PMID: 27614622     DOI: 10.1007/s10147-016-1040-7

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  30 in total

1.  Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.

Authors:  Tomoaki Terakawa; Hideaki Miyake; Mototsugu Muramaki; Atushi Takenaka; Isao Hara; Masato Fujisawa
Journal:  Urology       Date:  2008-01       Impact factor: 2.649

Review 2.  Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?

Authors:  Ingrid Müller; Markus Munder; Pascale Kropf; Gertrud Maria Hänsch
Journal:  Trends Immunol       Date:  2009-09-21       Impact factor: 16.687

3.  Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.

Authors:  S Hinotsu; H Akaza; Y Ohashi; T Kotake
Journal:  Cancer       Date:  1999-11-01       Impact factor: 6.860

Review 4.  Urothelial carcinoma of the bladder and the upper tract: disparate twins.

Authors:  David A Green; Michael Rink; Evanguelos Xylinas; Surena F Matin; Arnulf Stenzl; Morgan Roupret; Pierre I Karakiewicz; Douglas S Scherr; Shahrokh F Shariat
Journal:  J Urol       Date:  2012-09-27       Impact factor: 7.450

5.  Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial.

Authors:  Akihiro Ito; Ichiro Shintaku; Makoto Satoh; Naomasa Ioritani; Tatsuo Tochigi; Isao Numata; Takashige Namima; Koichi Kambe; Atsushi Kyan; Seiji Ueno; Shinnosuke Katoh; Hisanobu Adachi; Shinichi Yamashita; Takuhiro Yamaguchi; Yoichi Arai
Journal:  Jpn J Clin Oncol       Date:  2013-09-04       Impact factor: 3.019

6.  Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.

Authors:  Yuqing Liu; Jian Lu; Kai Hong; Yi Huang; Lulin Ma
Journal:  Urol Oncol       Date:  2013-04-28       Impact factor: 3.498

7.  Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.

Authors:  Hsin-Yuan Hung; Jinn-Shiun Chen; Chien Yuh Yeh; Chung-Rong Changchien; Reiping Tang; Pao-Shiu Hsieh; Wen-Sy Tasi; Jeng-Fu You; Yau-Tong You; Chung-Wei Fan; Jeng-Yi Wang; Jy-Ming Chiang
Journal:  Int J Colorectal Dis       Date:  2011-04-09       Impact factor: 2.571

8.  Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.

Authors:  Paulo C Rodriguez; Marc S Ernstoff; Claudia Hernandez; Michael Atkins; Jovanny Zabaleta; Rosa Sierra; Augusto C Ochoa
Journal:  Cancer Res       Date:  2009-02-05       Impact factor: 12.701

Review 9.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.

Authors:  Evanguelos Xylinas; Luis Kluth; Niccolo Passoni; Quoc-Dien Trinh; Malte Rieken; Richard K Lee; Harun Fajkovic; Giacomo Novara; Vitaly Margulis; Jay D Raman; Yair Lotan; Morgan Rouprêt; Atiqullah Aziz; Hans-Martin Fritsche; Alon Weizer; Juan I Martinez-Salamanca; Kazumasa Matsumoto; Christian Seitz; Mesut Remzi; Thomas Walton; Pierre I Karakiewicz; Francesco Montorsi; Marc Zerbib; Douglas S Scherr; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2013-09-19       Impact factor: 20.096

View more
  11 in total

1.  Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.

Authors:  Mihai Dorin Vartolomei; Shoji Kimura; Matteo Ferro; Liliana Vartolomei; Beat Foerster; Mohammad Abufaraj; Shahrokh F Shariat
Journal:  World J Urol       Date:  2018-02-21       Impact factor: 4.226

2.  Novel hematological biomarkers predict survival in renal cell carcinoma patients treated with nephrectomy.

Authors:  Paweł Rajwa; Marcin Życzkowski; Andrzej Paradysz; Monika Slabon-Turska; Kamil Suliga; Kamil Bujak; Piotr Bryniarski
Journal:  Arch Med Sci       Date:  2017-09-21       Impact factor: 3.318

3.  Predictors of Intravesical Recurrence After Radical Nephroureterectomy and Prognosis in Patients with Upper Tract Urothelial Carcinoma.

Authors:  Yun-Ren Li; Kai-Jie Yu; Ying-Hsu Chang; Po-Hung Lin; I-Hung Shao; Hung-Cheng Kan; Yuan-Cheng Chu; Cheng-Keng Chuang; See-Tong Pang; Chung-Yi Liu
Journal:  Cancer Manag Res       Date:  2020-08-19       Impact factor: 3.989

4.  Prognostic value of neutrophil-to-lymphocyte ratio in urothelial carcinoma of the upper urinary tract and bladder: a systematic review and meta-analysis.

Authors:  Xintao Li; Xin Ma; Lu Tang; Baojun Wang; Luyao Chen; Fan Zhang; Xu Zhang
Journal:  Oncotarget       Date:  2016-04-27

5.  Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma.

Authors:  Zhen-Peng Cao; Bao Guan; Guang-Zhi Zhao; Dong Fang; Geng-Yan Xiong; Xue-Song Li; Li-Qun Zhou
Journal:  Chin Med J (Engl)       Date:  2017-09-05       Impact factor: 2.628

6.  The complex relationship between upper urinary tract and bladder cancer: clinical and predictive issues.

Authors:  Francesca Sanguedolce; Luigi Cormio
Journal:  Transl Androl Urol       Date:  2018-05

Review 7.  Role of Systemic Inflammatory Response Markers in Urothelial Carcinoma.

Authors:  Hyeong Dong Yuk; Ja Hyeon Ku
Journal:  Front Oncol       Date:  2020-08-21       Impact factor: 5.738

8.  Prognostic scores based on the preoperative plasma fibrinogen and serum albumin level as a prognostic factor in patients with upper urinary tract urothelial carcinoma.

Authors:  Jianfeng Cui; Meng Yu; Ning Zhang; Shiyu Wang; Yaofeng Zhu; Shouzhen Chen; Kejia Zhu; Jian Du; Hongda Zhao; Xigao Liu; Pengxiang Chen; Wenbo Wang; Dongqing Zhang; Benkang Shi
Journal:  Oncotarget       Date:  2017-03-22

9.  Preoperative sterile pyuria as a prognostic biomarker for intravesical recurrence in upper urinary tract urothelial carcinoma.

Authors:  Byeong Jo Jeon; Bum Sik Tae; Hoon Choi; Jae Hyun Bae; Jong Wook Kim; Hong Seok Park; Jae Young Park
Journal:  Investig Clin Urol       Date:  2019-12-19

10.  Fragmentation of cell-free DNA is induced by upper-tract urothelial carcinoma-associated systemic inflammation.

Authors:  Kosuke Nakano; Yoshiyuki Yamamoto; Gaku Yamamichi; Satoru Yumiba; Eisuke Tomiyama; Makoto Matsushita; Yoko Koh; Yujiro Hayashi; Cong Wang; Yu Ishizuya; Taigo Kato; Koji Hatano; Atsunari Kawashima; Takeshi Ujike; Kazutoshi Fujita; Norio Nonomura; Motohide Uemura
Journal:  Cancer Sci       Date:  2020-11-12       Impact factor: 6.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.